Incarda Therapeutics Contact Us
Incarda Therapeutics, Inc
(646) 319-8981 Add photosOops! Something went wrong, please try again later.
- Website
- Directions
- Enroll
- Contact us
WEBInCarda Therapeutics, Inc. 39899 Balentine Drive, Suite 185 Newark, CA 94560. Australia Office. InCarda Therapeutics Australia Pty Ltd. Level 13, 41 Exhibition Street Melbourne, VIC 3000. Contact Information. [email protected]. We also use third …
See Also: Contact Support Preview / Show details
InCarda Therapeutics LinkedIn
WEBInCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Crunchbase Company Profile & Funding
WEBFounders Carlos A. Schuler, Gregory M. Marcus, John S. Patton, Narsi Rangachari. Operating Status Active. Last Funding Type Series C. Legal Name InCarda …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Announces Enrollment of First Patient
WEBJul 26, 2022 · InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for acute …
See Also: Phone Number Preview / Show details
Final Results from Phase 2 INSTANT Trial of InRhythm™ for
WEBNov 7, 2022 · About InCarda Therapeutics. InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Announces Enrollment of First U.S. Patient in
WEBJan 19, 2021 · About InCarda Therapeutics InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Company Profile Craft
WEBInCarda Therapeutics is a biopharmaceutical company researching an approach to treat cardiovascular diseases and conditions by the inhalation route. It develops an inhaled …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Raises $30 Million Through First Close
WEBOct 21, 2020 · InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for acute …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Overview, News & Similar companies
WEBAug 25, 2022 · Who is InCarda Therapeutics. InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled …
See Also: Phone Number Preview / Show details
Incarda Therapeutics, Inc. Company Profile Dun & Bradstreet
WEBFind company research, competitor information, contact details & financial data for Incarda Therapeutics, Inc. of Newark, CA. Get the latest business insights from Dun & Bradstreet.
See Also: Contact Support Preview / Show details
InCarda Therapeutics PitchBook
WEBDec 17, 2014 · 01-Oct-2012. $310K. $310K. Completed. Generating Revenue. To view InCarda Therapeutics’s complete valuation and funding history, request access ».
See Also: Phone Number Preview / Show details
InCarda Therapeutics Announces Enrollment of First U.S. Patient in
WEBJan 19, 2021 · InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Our Team
WEBThis website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your …
See Also: Phone Number Preview / Show details
InCarda Therapeutics News & Updates
WEBInCarda Presents Additional Phase 2 Data for InRhythm (Orally Inhaled Flecainide) at the 2022 European Society of Cardiology Congress in Barcelona. Read More. News Press …
See Also: Databases Preview / Show details
InCarda Therapeutics Announces Execution of Planned CEO …
WEBOct 4, 2022 · InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for acute …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Funding, Financials, Valuation & Investors
WEBInCarda Therapeutics has raised a total of. $77.9M. in funding over 7 rounds. Their latest funding was raised on Oct 21, 2020 from a Series C round. InCarda Therapeutics is …
See Also: Phone Number Preview / Show details
InCarda Therapeutics Pipeline Overview
WEBAtrial fibrillation (AF) is the most commonly encountered, sustained cardiac arrhythmia in clinical practice. The risk of developing AF increases with age and tends to be higher in …
See Also: Phone Number Preview / Show details